Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data

• Guo-Feng Chen ,

  Contributed equally to this work with: Guo-Feng Chen, Lai Wei, Jing Chen

  Affiliation Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China

  ⨯
• Lai Wei ,

  Contributed equally to this work with: Guo-Feng Chen, Lai Wei, Jing Chen

  Affiliation Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China

  ⨯
• Jing Chen ,

  Contributed equally to this work with: Guo-Feng Chen, Lai Wei, Jing Chen

  Affiliation Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China

  ⨯
• Zhong-Ping Duan,

  Affiliation The Translational Hepatology Institue, Beijing You'an Hospital, Capital University of Medicine, Beijing, China

  ⨯
• Xiao-Guang Dou,

  Affiliation Department of Infectious Diseases, Shengjing Hospital, China Medical University, Shenyang, China

  ⨯
• Qing Xie,

  Affiliation Department of Infectious diseases, Shanghai Ruijin Hospital, Jiaotong University, School of Medicine, Shanghai, China

  ⨯
• Wen-Hong Zhang,

  Affiliation Key Laboratory of Medical Molecular Virology, Huashan Hospital, Fudan University, Shanghai, China Institute of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Lun-Gen Lu,

  Affiliation Department of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  ⨯
• Jian-Gao Fan,

  Affiliation Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• Jun Cheng,

  Affiliation Liver Disease Center, Beijing Ditan Hospital, Capital University of Medicine, Beijing, China

  ⨯
• Gui-Qiang Wang,

  Affiliation Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China

  ⨯
• Hong Ren,

  Affiliation Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing, China

  ⨯
• Jiu-Ping Wang,

  Affiliation Department of Infectious Disease, Xijing Hospital, Fourth Military Medical University, Xi'an, China

  ⨯
• Xing-Xiang Yang,

  Affiliation Department of Infection, Sichuan Provincial People's Hospital, Chengdu, Sichuan, China

  ⨯
• Zhan-Sheng Jia,

  Affiliation Center of Diagnosis and Treatment for Infectious Diseases of Chinese PLA, Tangdu Hospital, Fourth Military Medical University, Xi’an, China

  ⨯
• Qing-Chun Fu,

  Affiliation Shanghai Liver Diseases Research Center, Nanjing Military Command, Shanghai, China

  ⨯
• Xiao-Jin Wang,

  Affiliation People’s Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China

  ⨯
• Jia Shang,

  Affiliation Department of Infectious Diseases, Henan Provincal People's Hospital, Zhengzhou University, Zhengzhou, China

  ⨯
• Yue-Xin Zhang,

  Affiliation Department of Infectious Disease, Xinjiang Medical University First Affiliated Hospital, Urumqi, China

  ⨯
• Ying Han,

  Affiliation Department of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi’an, China

  ⨯
• Ning Du,

  Affiliation Liver Disease Center for Combined Traditional Chinese Medicine and Western Medicine, 302 Hospital, Beijing, China

  ⨯
• Qing Shao,

  Affiliation Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China

  ⨯
• Dong Ji,

  Affiliation Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China

  ⨯
• Fan Li,

  Affiliation Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China

  ⨯
• Bing Li,

  Affiliation Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China

  ⨯
• Jia-Liang Liu,

  Affiliation Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China

  ⨯
• Xiao-Xia Niu,

  Affiliation Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China

  ⨯
• Cheng Wang,

  Affiliations Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China

  ⨯
• Vanessa Wu,

  Affiliation Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China

  ⨯
• April Wong,

  Affiliation Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China

  ⨯
• Yu-Dong Wang,

  Affiliation Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China

  ⨯
• Jin-Lin Hou,

  Affiliation State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China

  ⨯
• Ji-Dong Jia,

  Affiliation Liver Disease Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China

  ⨯
• Hui Zhuang,

  Affiliation Department of Microbiology and Center of Infectious Disease, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China

  ⨯
•  [ ... ],
• George Lau

  * E-mail: gkklau@netvigator.com

  Affiliations Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China, Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China

  ⨯
• [ view all ]
• [ view less ]